Biontech vaccine more stable than expected

us-capitol

So far, the Biontech / Pfizer corona vaccine has been considered a bit complicated to use. This mainly applies to cooling at very low temperatures. Now there is new data that make handling much easier. And the problem of delivery delays also seems to be resolving. The preparation from the manufacturers Biontech and Pfizer can be used more easily in the future for corona vaccinations in Germany. As Biontech’s updated recommendations for action show, the vaccine can be transported as a finished dose in the syringe for up to six hours at two to eight degrees Celsius. That would have resulted in new data on the stability of the vaccine.

Biontech, Moderna & Co. What do manufacturers earn from the corona vaccine?

Federal Health Minister Jens Spahn said this is good news, especially for those in need of care who are waiting at home for a vaccination. The countries could now organize the vaccination campaign more flexibly. “The fact that finished vaccination doses in syringes can in future be prepared for transport in the vaccination centers is very practical in the fight against the pandemic.” So far, it has been recommended not to transport already diluted vaccine between facilities – i.e. between the vaccination centers of the countries where the preparation is stored at minus 70 degrees and nursing homes or assisted living facilities in which vaccination is to be carried out. According to Biontech, the diluted vaccine can be stored for a maximum of six hours at 2 to 30 degrees. If necessary, it can be diluted at the vaccination center and then carefully transported in the syringe as a prepared dose. Special cool boxes should be used for this. Syringes or vials should be securely wrapped so that they stand upright and are not loose or rolling. Six instead of five vaccine doses can now be drawn from one ampoule.

Rebuilding at the Belgian plant in Pfizer temporarily supplies less vaccine

On Friday, the Federal Ministry of Health announced that Biontech / Pfizer would reduce their vaccine deliveries to Germany and other European countries for three to four weeks due to renovation work at the Pfizer plant in Puurs, Belgium. There was then clear criticism from several governments. In a message from Pfizer and its German partner Biontech on Friday evening, it said: “From the week of January 25, we will return to the original schedule for deliveries to the European Union (100 percent) and deliveries from the week of January 15 February increase (over 100 percent) so we will be able to deliver the full promised amount of vaccine doses in the first quarter and significantly more in the second quarter. ” The vaccine from Biontech / Pfizer was the first to be approved in the EU at the end of 2020, and the preparation from the US manufacturer Moderna is now also being used in Germany.

(Visited 1 times, 1 visits today)

Tags: suchen suche search tag anzeigen besucherzahl browser design domain inhalt jahr karpfen konto problem inhalt schalten modellbahn spielemax spiel tag webseite preise werbung

Reichsmarschall Göring hatte eine Märklin Modelleisenbahn >>> read more




ID for Download Paper 51787